Advisor Group Holdings, Inc. Immunity Bio, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 103,192 shares of IBRX stock, worth $315,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,192
Previous 74,854
37.86%
Holding current value
$315,767
Previous $473,000
19.24%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
205Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$51.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$35 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$26.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$11.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$6.88 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.22B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...